News & Press

The National Association of Medicaid Fraud Control Units Announces a $35 million dollar settlement with Walgreens

Patient Safety and Abuse Prevention Act of 2007

Forty-one Attorneys General and three state authorities that house Medicaid Fraud Control Units signed a letter to members of Congress in support of the Patient Safety and Abuse Prevention Act of 2007 (S. 1577, H.R. 3078), which would establish a system of screening and national criminal history background checks for prospective workers in nursing homes and other long-term care programs.

Merck settles for $649 million for failure to pay Medicaid rebates

The National Association of Medicaid Fraud Control Units (NAMFCU) announces $9.8 million settlement with Medicis.

Aventis Pharmaceuticals Inc. Held Accountable for Defrauding State Medicaid Programs In A Drug Pricing Scheme

The National Association of Medicaid Fraud Control Units (“NAMFCU”) Enters into Settlement with Purdue Pharmaceuticals

The National Association of Medicaid Fraud Control Units (“NAMFCU”) announced on October 3, 2001, that it has reached an agreement in principle with TAP Pharmaceutical Products, Inc. (“TAP”)

The National Association of Medicaid Fraud Control Units (NAMFCU) announced on April 16 the largest Medicaid fraud settlement ever involving pharmaceutical manufacturers.

The National Association of Medicaid Fraud Control Units (“NAMFCU”) announced on July 30, 2004, that it has reached an agreement in principle with pharmaceutical manufacturer Schering Plough, (“Schering”)

NAMFCU Enters Into $435 Million National Settlement With Schering-Plough

NAMFCU Reaches Settlement with Pediatrix Medical Group

NAMFCU Settles With Drug Maker Glaxo SmithKline in $149 million National Settlement

The National Association of Medicaid Fraud Control Units (NAMFCU) announces a $262 million dollar settlement that the Medicaid programs of 42 states and the District of Columbia reached with Serono, S.A.

Personal tools

National Association of Medicaid Fraud Control Units

Sections

Document Actions

The National Association of Medicaid Fraud Control Units Announces a $35 million dollar settlement with Walgreens

Patient Safety and Abuse Prevention Act of 2007

Merck settles for $649 million for failure to pay Medicaid rebates

The National Association of Medicaid Fraud Control Units (NAMFCU) announces $9.8 million settlement with Medicis.

Aventis Pharmaceuticals Inc. Held Accountable for Defrauding State Medicaid Programs In A Drug Pricing Scheme

The National Association of Medicaid Fraud Control Units (“NAMFCU”) Enters into Settlement with Purdue Pharmaceuticals

The National Association of Medicaid Fraud Control Units (“NAMFCU”) announced on October 3, 2001, that it has reached an agreement in principle with TAP Pharmaceutical Products, Inc. (“TAP”)

The National Association of Medicaid Fraud Control Units (NAMFCU) announced on April 16 the largest Medicaid fraud settlement ever involving pharmaceutical manufacturers.

The National Association of Medicaid Fraud Control Units (“NAMFCU”) announced on July 30, 2004, that it has reached an agreement in principle with pharmaceutical manufacturer Schering Plough, (“Schering”)

NAMFCU Enters Into $435 Million National Settlement With Schering-Plough

NAMFCU Reaches Settlement with Pediatrix Medical Group

NAMFCU Settles With Drug Maker Glaxo SmithKline in $149 million National Settlement

The National Association of Medicaid Fraud Control Units (NAMFCU) announces a $262 million dollar settlement that the Medicaid programs of 42 states and the District of Columbia reached with Serono, S.A.